基因编辑

• SeQure Dx Announces $17.5M Series A Funding 2021-08-03
• PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech 2021-06-22
• Metagenomi Extends Series A Financing from RA Capital and Welcomes Andrew Levin to Its Board of Directors 2021-04-07
• Editas Medicine Announces Pricing of Offering of Common Stock 2021-01-21
• Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease 2021-01-19
• Cellectis Announces Launch of Follow-On Offering 2020-12-15
• Spotlight Therapeutics Closes $30M Series A Led by GV to Advance Pipeline of Non-viral CRISPR Gene Editing Biologics 2020-11-30
• Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement 2020-11-20
• Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund 2020-11-12
• Locus Biosciences signs contract with CARB-X to advance $14 million precision medicine program to develop crPhage™ product targeting Klebsiella pneumoniae infections 2020-11-10

登录医药魔方官网 查看更多资讯